MEDIPEN 1500
Inj. Meropenem 1G+Sulbactam 500MG
- Greater efficacy than the combinations of ceftazidime plus amikacin or tobramycin in patients with nosocomial pneumonia.
- More effective than ceftazidime-based combination treatments in patients with nosocomial lower respiratory tract infections (LRTIs)
- Stable against hydrolysis by most ẞ-lactamases, including ESBLS and AmpC ß-lactamases
